PhD Position: Cognitive Functioning after Cancer – Evaluation of a 12‑Week Integrative Program
📍 KU Leuven • Leuven, Flanders, Belgium
Post-doctoral Research Scientist – Stem Cell Biology to Model Sporadic Alzheimer’s Disease
📍 VIB • Leuven, Flanders, Belgium
Bioanalytical Scientific Manager (Belgium)
📍 UCB • Braine-l'Alleud, Walloon Region, Belgium
Project Finance Analyst
📍 Viroclinics Biosciences • Ghent, Flanders, Belgium
Director, Computational Multiomics, Neuroscience
📍 Johnson and Johnson • Beerse, Flanders, Belgium
Project Manager - Lab Services
📍 Viroclinics Biosciences • Ghent, Flanders, Belgium
Senior Drug Discovery Scientist
📍 VIB • Leuven, Flanders, Belgium
Probing the methylome in cardiac remodelling in pathology and aging to discover biomarkers of health and mechanisms underlying transcriptional changes.
📍 KU Leuven • Leuven, Flanders, Belgium
Post-doctoral Research Scientist – Stem Cell Biology to Model Sporadic Alzheimer’s Disease
📍 KU Leuven • Leuven, Flanders, Belgium
Director, Computational Multiomics, Neuroscience
📍 Johnson and Johnson • Beerse, Flanders, Belgium
Postdoc position in Metabolomics/Lipidomics
📍 Universiteit Antwerpen • Antwerp, Flanders, Belgium
Associate Director, Clinical Scientist (Biomarker Integration, Neuroscience)
📍 J&J Family of Companies • Beerse, Belgium, Belgium
PhD insectengif allergie
📍 KU Leuven • Leuven, Flanders, Belgium
PhD insect venom allergy
📍 KU Leuven • Leuven, Flanders, Belgium
PhD neuroscience position in vivo neuroimaging and electrophysiology following developmental Huntingtin modulation
📍 Universiteit Antwerpen • Antwerp, Flanders, Belgium
Senior Drug Discovery Scientist
📍 VIB • Leuven, Flanders, Belgium
Biomarker Biostatistics Lead
📍 Argenx • Ghent, Flanders, Belgium
PhD (Immuno-oncology): Toward valorising cancer immunotherapy
📍 KU Leuven • Leuven, Flanders, Belgium
Post-doctoral Research Scientist – Stem Cell Biology to Model Sporadic Alzheimer’s Disease
📍 VIB • Leuven, Flanders, Belgium
Doctoral scholarship holder in vivo neuroimaging with a focus on safety imaging biomarkers in animal models relevant for non-allele selective treatments of Huntington’s disease
📍 Universiteit Antwerpen • Antwerp, Flanders, Belgium